Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 1
2018 5
2019 5
2020 4
2021 8
2022 13
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Design, synthesis and antiviral evaluation of novel conjugates of the 1,7,7-trimethylbicyclo[2.2.1]heptane scaffold and saturated N-heterocycles via 1,2,3-triazole linker.
Sokolova AS, Yarovaya OI, Artyushin OI, Sharova EV, Baev DS, Mordvinova ED, Shcherbakov DN, Shnaider TA, Nikitina TV, Esaulkova IL, Ilyina PA, Zarubaev VV, Brel VK, Tolstikova TG, Salakhutdinov NF. Sokolova AS, et al. Among authors: yarovaya oi. Arch Pharm (Weinheim). 2024 Mar;357(3):e2300549. doi: 10.1002/ardp.202300549. Epub 2023 Nov 30. Arch Pharm (Weinheim). 2024. PMID: 38036303
Corrigendum: The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper.
Belenkaya SV, Merkuleva IA, Yarovaya OI, Chirkova VY, Sharlaeva EA, Shanshin DV, Volosnikova EA, Vatsadze SZ, Khvostov MV, Salakhutdinov NF, Shcherbakov D. Belenkaya SV, et al. Among authors: yarovaya oi. Front Bioeng Biotechnol. 2023 Nov 6;11:1294266. doi: 10.3389/fbioe.2023.1294266. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 38026885 Free PMC article.
The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper.
Belenkaya SV, Merkuleva IA, Yarovaya OI, Chirkova VY, Sharlaeva EA, Shanshin DV, Volosnikova EA, Vatsadze SZ, Khvostov MV, Salakhutdinov NF, Shcherbakov DN. Belenkaya SV, et al. Among authors: yarovaya oi. Front Bioeng Biotechnol. 2023 Jun 29;11:1187761. doi: 10.3389/fbioe.2023.1187761. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37456729 Free PMC article.
Development of an LC-MS/MS-based method for quantification and pharmacokinetics study on SCID mice of a dehydroabietylamine-adamantylamine conjugate, a promising inhibitor of the DNA repair enzyme.
Okhina AA, Rogachev AD, Kovaleva KS, Yarovaya OI, Khotskina AS, Zavyalov EL, Vatsadze SZ, Pokrovsky AG, Salakhutdinov NF. Okhina AA, et al. Among authors: yarovaya oi. J Pharm Biomed Anal. 2023 Sep 20;234:115507. doi: 10.1016/j.jpba.2023.115507. Epub 2023 Jun 7. J Pharm Biomed Anal. 2023. PMID: 37331915
Structure-Based Design, Synthesis, and Biological Evaluation of the Cage-Amide Derived Orthopox Virus Replication Inhibitors.
Mozhaitsev ES, Suslov EV, Rastrepaeva DA, Yarovaya OI, Borisevich SS, Khamitov EM, Kolybalov DS, Arkhipov SG, Bormotov NI, Shishkina LN, Serova OA, Brunilin RV, Vernigora AA, Nawrozkij MB, Agafonov AP, Maksyutov RA, Volcho KP, Salakhutdinov NF. Mozhaitsev ES, et al. Among authors: yarovaya oi. Viruses. 2022 Dec 21;15(1):29. doi: 10.3390/v15010029. Viruses. 2022. PMID: 36680072 Free PMC article.
42 results